Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 486

Results For "ABLE"

6179 News Found

National Health Authority releases consultation paper on Drug Registry
News | March 31, 2022

National Health Authority releases consultation paper on Drug Registry

The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country


USFDA approves Edwards Mitris Resilia valve
Medical Device | March 31, 2022

USFDA approves Edwards Mitris Resilia valve

The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve


We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India
interviews | March 30, 2022

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com


ASC Therapeutics gets green light to advance gene therapy for Hemophilia A
Biotech | March 30, 2022

ASC Therapeutics gets green light to advance gene therapy for Hemophilia A

A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies


SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics
Hospitals | March 30, 2022

SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics

The SRV LHPL centre of excellence in robotic orthopaedics will be helmed by joint replacement surgeon, Dr Narendra Vaidya


Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Drug Approval | March 30, 2022

Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors

Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding


Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies
Public Health | March 30, 2022

Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies

India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.


Medtronic commences PRAAN registry for stroke patients
Medical Device | March 30, 2022

Medtronic commences PRAAN registry for stroke patients

The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects
Drug Approval | March 30, 2022

USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects

Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint